Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Marrying the Business with the Science

25:44
 
Share
 

Manage episode 513792938 series 1016848
Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sam Kulkarni, PhD, CEO and Chairman of CRISPR Therapeutics, joins Venrock's Nimish Shah for a conversation about how they're using gene editing to find potential cures so miraculous, it almost sounds like science fiction. Sam shares advice on how to fundraise in the extraordinarily capital-intensive biotech market, having the courage to go after difficult things and face detractors, and how CEOs should find opportunity in volatility.

  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 513792938 series 1016848
Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sam Kulkarni, PhD, CEO and Chairman of CRISPR Therapeutics, joins Venrock's Nimish Shah for a conversation about how they're using gene editing to find potential cures so miraculous, it almost sounds like science fiction. Sam shares advice on how to fundraise in the extraordinarily capital-intensive biotech market, having the courage to go after difficult things and face detractors, and how CEOs should find opportunity in volatility.

  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play